Related references
Note: Only part of the references are listed.Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort
M. Serper et al.
JOURNAL OF VIRAL HEPATITIS (2018)
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals
V. Calvaruso et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV
Eiichi Ogawa et al.
LIVER INTERNATIONAL (2018)
Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals
Jacinta A. Holmes et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Hepatitis B Reactivation in Hepatitis B and C Coinfected Patients Treated With Antiviral Agents: A Systematic Review and Meta-analysis
Guofeng Chen et al.
HEPATOLOGY (2017)
Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated With Oral Hepatitis C Antivirals
Pamela S. Belperio et al.
HEPATOLOGY (2017)
Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort
Akira Doi et al.
HEPATOLOGY RESEARCH (2017)
Hepatitis B virus reactivation among hepatitis C patients treated with directacting antiviral therapies in routine clinical practice
Elisabetta Loggi et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals
Ming-Lun Yeh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
EASL Recommendations on Treatment of Hepatitis C 2016
JOURNAL OF HEPATOLOGY (2017)
Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up
Hsing-Yu Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2017)
Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C
N. Kawagishi et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
Chen-Hua Liu et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Cheng Wang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort
V. T. Muecke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the US Food and Drug Administration Adverse Event Reporting System
Susan J. Bersoff-Matcha et al.
ANNALS OF INTERNAL MEDICINE (2017)
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
Salvatore Petta et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen
M. -C. Londono et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study
R. Flisiak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV
Edward J. Gane et al.
ANTIVIRAL THERAPY (2016)
Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System
George N. Ioannou et al.
GASTROENTEROLOGY (2016)
Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge
Anne De Monte et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
New therapies for chronic hepatitis B
Maya Bitton Alaluf et al.
LIVER INTERNATIONAL (2016)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
Role of occult hepatitis B virus infection in chronic hepatitis C
Nicola Coppola et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania
Ileana Constantinescu et al.
HEPATITIS MONTHLY (2014)
Clinical Outcomes of Hepatitis B Virus Coinfection in a United States Cohort of Hepatitis C Virus-Infected Patients
Robert L. Kruse et al.
HEPATOLOGY (2014)
Management of patients with hepatitis B who require immunosuppressive therapy
Jessica P. Hwang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Hepatitis B virus and hepatitis C virus dual infection
Gaia Caccamo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey
Liana Gheorghe et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients
Gia L. Tyson et al.
HEPATOLOGY (2013)
Management of acute hepatitis B and reactivation of hepatitis B
Ankur Jindal et al.
LIVER INTERNATIONAL (2013)
Prevalence of viral hepatitis (B and C) serological markers in healthy working population
José Luis Calleja-Panero et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2013)
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection
N. Coppola et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Hepatitis B reactivation and current clinical impact
B. Álvarez Suárez et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2010)
Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
Yun-Fan Liaw
LIVER INTERNATIONAL (2009)
Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment
Chi-Jen Chu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients
G Raimondo et al.
HEPATOLOGY (2006)
Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
YF Liaw
JOURNAL OF GASTROENTEROLOGY (2002)
Share Paper
